These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 2483952

  • 21. The augmentation of tumor-specific immunity by virus help. I. Demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of cytotoxic T lymphocyte and antibody responses.
    Fujiwara H, Shimizu Y, Takai Y, Wakamiya N, Ueda S, Kato S, Hamaoka T.
    Eur J Immunol; 1984 Feb; 14(2):171-5. PubMed ID: 6199215
    [Abstract] [Full Text] [Related]

  • 22. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.
    Miller SD, Butler LD, Cleveland RP, Moorhead JW, Claman HN, Chiller JC.
    Cell Immunol; 1983 Dec; 82(2):378-93. PubMed ID: 6197193
    [Abstract] [Full Text] [Related]

  • 23. Relationship between trinitrophenyl and H-2 antigens on trinitrophenyl-modified spleen cells. I. H-2 antigens on cells treated with trinitrobenzene sulfonic acid are derivatized.
    Forman J, Vitetta ES, Hart DA, Klein J.
    J Immunol; 1977 Mar; 118(3):797-802. PubMed ID: 66272
    [Abstract] [Full Text] [Related]

  • 24. Augmentation of antitumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2- T-cell-mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers.
    Suda T, Fujiwara H, Mizushima Y, Shearer GM, Hamaoka T.
    J Natl Cancer Inst; 1986 Dec; 77(6):1267-72. PubMed ID: 2948049
    [Abstract] [Full Text] [Related]

  • 25. In vivo development of cytolytic T lymphocytes (CTL) to hapten-altered self: MIs-disparate cells facilitate the response by neutralizing IL 2 inhibitor.
    Gautam SC, Hilfiker ML, Battisto JR.
    J Immunol; 1983 Feb; 130(2):533-7. PubMed ID: 6217243
    [Abstract] [Full Text] [Related]

  • 26. Role of the major histocompatibility complex in T cell activation of B cell subpopulations: antigen-specific and H-2-restricted monoclonal TH cells activate Lyb-5+ B cells through an antigen-nonspecific and H-2-unrestricted effector pathway.
    Hodes RJ, Shigeta M, Hathcock KS, Fathman CG, Singer A.
    J Immunol; 1982 Jul; 129(1):267-71. PubMed ID: 6177752
    [Abstract] [Full Text] [Related]

  • 27. Decline, in aging mice, of the anti-2,4,6-trinitrophenyl (TNP) cytotoxic T cell response attributable to loss of Lyt-2-, interleukin 2-producing helper cell function.
    Miller RA, Stutman O.
    Eur J Immunol; 1981 Oct; 11(10):751-6. PubMed ID: 6975716
    [Abstract] [Full Text] [Related]

  • 28. The origin of cytotoxic T lymphocyte precursors (CTL-P): MHC-restricted and alloreactive CTL-P in the spleen during regeneration after a sublethal dose of cyclophosphamide (Cy).
    Sihvola M, Hurme M.
    J Immunol; 1983 Mar; 130(3):1077-83. PubMed ID: 6600471
    [Abstract] [Full Text] [Related]

  • 29. Generation of anti-hapten T cell cytotoxicity in vivo. Relationship to contact sensitivity and the role of contrasuppression.
    Ptak W, Friedman AM, Flood PM.
    Arch Immunol Ther Exp (Warsz); 1994 Mar; 42(3):185-92. PubMed ID: 7487350
    [Abstract] [Full Text] [Related]

  • 30. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
    Singer A, Kruisbeek AM, Andrysiak PM.
    J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
    [Abstract] [Full Text] [Related]

  • 31. Cell-mediated lympholytic responses against autologous cells modified with haptenic sulfhydryl reagents. V. H-2Ld self products are recognized by anti-AED-specific cytotoxic T cells.
    Levy RB, Shearer GM.
    J Immunol; 1983 Apr; 130(4):1506-11. PubMed ID: 6187809
    [Abstract] [Full Text] [Related]

  • 32. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. II. Development of syngeneic cytotoxicity in the absence of specific antigenic stimulation.
    Claesson MH, Miller RG.
    J Immunol; 1985 Feb; 134(2):684-90. PubMed ID: 2578160
    [Abstract] [Full Text] [Related]

  • 33. Reactivity of Ly-2+ T cells against 2,4,6-trinitrophenyl (TNP)-modified syngeneic stimulator cells: specificity, frequency of interleukin 2-producing Ly-2+ helper T cells and clonal segregation from Ly-2+ cytotoxic T lymphocytes.
    Schmitt J, Wagner H, Heeg K.
    Eur J Immunol; 1988 Mar; 18(3):325-32. PubMed ID: 2965642
    [Abstract] [Full Text] [Related]

  • 34. Limiting dilution analysis of induced unresponsiveness to trinitrophenyl: increased suppression of cytotoxic T precursor cells at unchanged frequencies.
    Cooper JM, Eichmann K.
    J Mol Cell Immunol; 1985 Mar; 2(2):83-94. PubMed ID: 3880510
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M, Orosz CG, Bach FH.
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [Abstract] [Full Text] [Related]

  • 38. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
    Fujiwara H, Yoshioka T, Shima J, Kosugi A, Itoh K, Hamaoka T.
    J Immunol; 1986 Apr 01; 136(7):2715-9. PubMed ID: 3005417
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.